CYBIN INC. overview

EQS Newswire / 19/06/2024 / 21:51 EST/EDT In the past, many notable figures have suffered from depression, with some even taking their own lives, earning depression the moniker of the "number one mental killer." According to a survey by the World Health Organization, 322 million people globally suffer from depression, accounting for 4.4% of the world's total population. In recent years, the impact of the pandemic coupled with advancements in AI technology and the increasing disconnect in human...

EQS Newswire / 31/10/2023 / 21:41 EST/EDT Undervalued pharmaceutical stock Cybin emerges as market pioneer The stock market, being a zero-sum game, often presents opportunities to identify severely undervalued stocks, although these opportunities are typically recognized by only a few astute investors. In this context, consider the following: a market valued at 40 billion USD, yet its leader has only a market capitalization of only 200 million USD. After reading this article, would investors be...

EQS Newswire / 20/09/2023 / 21:01 EST/EDT Wall Street Hedge Fund Genius Bets on Cybin Inc. Is a 1:29 investment about to happen again? Hedge fund Point72 Asset Management, following its successful $3 investment in Immunomedics (NASDAQ: IMMU) that skyrocketed to $87 before being acquired, is now placing its latest bet on a company that holds hope for over a hundred million depression patients worldwide: Cybin Inc. (NASDAQ: CYBN). Founded by Wall Street hedge fund genius Steve Cohen, Point72 Asset...

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) announces the availability of a broadcast titled, “Psychedelic Therapies Offer Hope for Mental Health.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/JeGwq There’s strong belief that different classes of psychedelics, such as ketamine, psilocybin, DMT and MDMA, can be developed for a wide...

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Psychedelic Therapies Offer Hope for Mental Health,” please visit: https://nnw.fm/JeGwq Neural plasticity is...